1. Home
  2. Blog
  3. Susceptibility to SARS-Cov-2 Infection and Risk for Severe COVID-19 in Patients with Prostate Cancer on Androgen Deprivation Therapy

Susceptibility to SARS-Cov-2 Infection and Risk for Severe COVID-19 in Patients with Prostate Cancer on Androgen Deprivation Therapy

Monday, September 30th 2024

Gedeborg R, Loeb S, Styrke J, Kiiski-Berggren R, Garmo H, Stattin P.

“Susceptibility to SARS-Cov-2 Infection and Risk for Severe COVID-19 in Patients with Prostate Cancer on Androgen Deprivation Therapy.”

Int J Cancer. 2022 Jul 8. PMID: 35802468.

Link: https://pubmed.ncbi.nlm.nih.gov/35802468/

Comments are closed.